SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-071189
Filing Date
2022-11-10
Accepted
2022-11-10 16:16:35
Documents
76
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_aikidopharm.htm   iXBRL 10-Q 884436
2 CERTIFICATION f10q0922ex31-1_aikidopharma.htm EX-31.1 10056
3 CERTIFICATION f10q0922ex31-2_aikidopharma.htm EX-31.2 10061
4 CERTIFICATION f10q0922ex32-1_aikidopharma.htm EX-32.1 4338
  Complete submission text file 0001213900-22-071189.txt   5450883

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE aiki-20220930.xsd EX-101.SCH 76029
6 XBRL CALCULATION FILE aiki-20220930_cal.xml EX-101.CAL 34336
7 XBRL DEFINITION FILE aiki-20220930_def.xml EX-101.DEF 279996
8 XBRL LABEL FILE aiki-20220930_lab.xml EX-101.LAB 593480
9 XBRL PRESENTATION FILE aiki-20220930_pre.xml EX-101.PRE 305638
70 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_aikidopharm_htm.xml XML 654117
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-05576 | Film No.: 221377445
SIC: 8731 Services-Commercial Physical & Biological Research